Case Study: a specialty pharmaceutical company boosts profitability and operational efficiency with Maine Pointe

Specialty Pharmaceutical Company boosts gross profitability 14.4% with Maine Pointe

A specialty pharmaceutical company, a private equity-backed carve-out of an API manufacturer, faced the urgent challenge of standing up as an independent entity within 14 weeks. Post-divestiture, it struggled with high costs, inefficient procurement and logistics, and a lack of standardized processes. Maine Pointe was engaged to address these issues.

Maine Pointe implemented a comprehensive solution including new procurement processes, a shift from air to ocean freight, optimized production scheduling, and the creation of cross-functional teams. They also installed management operating systems and provided capability training. The results delivered by Maine Pointe included a 14.4% improvement in gross profitability, a 24% reduction in direct spend, a 20% cut in labor costs while maintaining output, and a 3.2:1 ROI, alongside a transition to a more proactive culture.